Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials.

Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials. J Nucl Cardiol. 2015 Oct; 22(5):1008-18.

View in: PubMed

subject areas

Adenosine A2 Receptor Agonists
Adult
Aged
Aminophylline
Cardiotonic Agents
Double-Blind Method
Drug Administration Schedule
Exercise Test
Female
Gastrointestinal Tract
Glomerular Filtration Rate
Humans
Kidney Failure, Chronic
Male
Middle Aged
Myocardial Perfusion Imaging
Purines
Pyrazoles
Renal Insufficiency, Chronic

authors with profiles

Rami Doukky